Nekro Veyxym, Injekční suspenze
Nekro Veyxym, Injekční suspenze
Authorised
- Chymotrypsin
- Trypsin
- Papain
Product identification
Medicine name:
Nekro Veyxym, Injekční suspenze
Active substance:
- Chymotrypsin
- Trypsin
- Papain
Target species:
-
Goat
-
Sheep
-
Pig
-
Cattle
-
Dog
Route of administration:
-
Intramuscular use
Product details
Active substance and strength:
-
Chymotrypsin1200.00FIP1.00millilitre(s)
-
Trypsin120.00FIP1.00millilitre(s)
-
Papain15.00FIP1.00millilitre(s)
Pharmaceutical form:
-
Suspension for injection
Withdrawal period by route of administration:
-
Intramuscular use
- Goat
-
Meat and offal0day
-
Milk0hour
-
- Sheep
-
Meat and offal0day
-
Milk0hour
-
- Pig
-
Meat and offal0day
-
- Cattle
-
Meat and offal0day
-
Milk0hour
-
- Dog
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QD03BA52
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Czechia
Available in:
-
Czechia
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Veyx Pharma GmbH
Marketing authorisation date:
Manufacturing sites for batch release:
- Veyx Pharma GmbH
Responsible authority:
- Institute For State Control Of Veterinary Biologicals And Medicaments
Authorisation number:
- 96/118/04-C
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
This document does not exist in this language (English). You can find it in another language below.
Czech (PDF)
Published on: 26/10/2022
Labelling
This document does not exist in this language (English). You can find it in another language below.
Czech (PDF)
Published on: 26/10/2022
Package Leaflet
This document does not exist in this language (English). You can find it in another language below.
Czech (PDF)
Published on: 26/10/2022
How useful was this page?: